Chang Gyu-Tae, Min Sang-Yeon, Kim Jang-Hyun, Kim Sung-Hoon, Kim June-Ki, Kim Cheorl-Ho
Department of Pediatrics, Dongguk University and National Research Laboratory for Glycobiology and Cardiovascular Medical Research Center, Sukjang-Dong 707, Kyungju City, Kyungbuk 780-714, South Korea.
Vascul Pharmacol. 2005 Oct;43(4):283-8. doi: 10.1016/j.vph.2005.08.014. Epub 2005 Oct 14.
The anti-thrombic properties of the Korean herbal medicine, Dae-Jo-Hwan (DJW), which is consisted of 11 herbs (indicated as concentrations) of Rehmanniae radix 24%, Hominis placenta 5%, Testudinis carapax 9%, Eucommiae cortex 9%, Asparagi radix 9%, Phellodendri cortex 9%, Achyranthis radix 7%, Liriopis tuber 7%, Angelicae sinensis radix 7%, Ginseng radix 6%, and Schizandrae fructus 3%, were investigated. The extracts of DJW and its 11 herbs, except G. radix, A. sinensis radix and S. Fructus, inhibited the endotoxin-induced hepatic venous thrombosis in high cholesterol diet-treated rats. Also the extract inhibited the endotoxin-induced decrease in blood platelets and fibrinogen, and endotoxin-induced increase in fibrin degradation products (FDP) on disseminated intravascular coagulation in normal rats. In in vitro experiments, the extract was shown to have inhibitory effect on collagen- and ADP-induced blood platelet aggregation, on thrombin-induced conversion of fibrinogen to fibrin and on the activity of plasminogen or plasmin. In conclusion, the protection of extracts of Korean herbs on the ischemic infarction induced artificially might be related to their inhibitory effects on DIC, platelet coagulation and thrombic action.
大造丸(DJW)是一种由11种草药组成的韩国草药,这些草药(以浓度表示)包括地黄24%、紫河车5%、龟甲9%、杜仲9%、天冬9%、黄柏9%、牛膝7%、麦冬7%、当归7%、人参6%和五味子3%,对其抗血栓特性进行了研究。除人参、当归和五味子外,DJW及其11种草药的提取物可抑制高胆固醇饮食喂养大鼠的内毒素诱导的肝静脉血栓形成。此外,该提取物还可抑制内毒素诱导的正常大鼠血小板和纤维蛋白原减少以及内毒素诱导的弥散性血管内凝血中纤维蛋白降解产物(FDP)增加。在体外实验中,该提取物对胶原和ADP诱导的血小板聚集、凝血酶诱导的纤维蛋白原向纤维蛋白的转化以及纤溶酶原或纤溶酶的活性具有抑制作用。总之,韩国草药提取物对人工诱导的缺血性梗死的保护作用可能与其对弥散性血管内凝血、血小板凝血和血栓形成作用的抑制有关。